From CLSDF's Adam Rubenstein: "If you have not heard about the upcoming Rocky Mountain Life Science Investor Conference at the Ritz Carlton – Denver on 17 September, yet, you sure will get an earful about it here at CLSDF.Today’s post particularly applies to those companies who have applied to present at the RMLSIC and were not selected as well as those entities who have not applied (perhaps you thought you were not ready to present yet?). Knowing that capital raising in our world is essentially, well…essential, the perspective of institutional life science investors is key in helping to highlight and address the critical “commercially relevant” questions that an early-stage entity must focus upon in order to efficiently leverage finite resources."
No comments:
Post a Comment